Non-enzymatic glycosylation of low-density lipoprotein. Results of an affinity chromatography method Dear Sir, Lyons et al. [1] previously published results showing that human low-density lipoprotein (LDL) is glycosylated in vivo to a greater extent in diabetic patients than in non-diabetic subjects. We present a simplified affinity chromatography method which confirms and extends Lyons' results [2] . Glycosylated LDL was measured by affinity chromatography with m~aminophenylboronate gel. LDL was prepared from plasma using sequential ultracentrifugation employing a density gradient method with varying densities of potassium bromide [3]. Transparent plastic minicolumns (Amicon Ltd, Stonehouse, Glos, UK) containing 1 ml of affinity gel (Glycogel B, Pierce Ltd, Cambridge, UK) were prepared and equilibrated with 5 ml of ammonium acetate-based wash buffer (250 retool/1 ammonium acetate, 50mmol/1 magnesium chloride, 500mmol/1 sodium chloride, 3 retool/1 sodium azide, 0.1% Tween 20 detergent, pH adjusted to 8.5 at 20 1 ~ To each column a 400 p,1 aliquot of LDL was added and allowed to soak into the gel. Then 9.6 ml of wash buffer was added (in divided aliquots) to the gel column and allowed to drain into the gel. Thus, non-glycosylated LDL was collected in a 'wash buffer' eluate of total volume 10 ml. The collecting vessel was changed and the glycosylated LDL fraction was eluted from the gel column by adding 4ml of sorbitol elution buffer (200mmol/1 sorbitol, 500 retool/1 sodium chloride, 50 retool/1 Na2 EDTA, 100 mmol.l Tris, 0.1% Tween 20, pH adjusted to 8.5 at 20_+ 1 ~ The cholesterol in the glycosylated ('elution buffer') and non-glycosylated ('wash buffer') fractions was assayed spectrophotometrically using an enzymatic colorimetric method (cholesterol C-system high performance, Boehringer Ltd, Lewes, Sussex, UK). Blank corrections were made by the use of a column to which distilled water had been added instead of LDL. Zero settings on the spectrophotometer were taken using the 'wash' and 'elution' eluates of the blank. Using the cholesterol reagent it was shown that Beer's Law was obeyed for absorbances up to 0.5, and thus the absorbances of the 'wash' and 'elution' buffer eluates could be used as measures of the LDL cholesterol in either non-glycosylated or glycosylated fractions. Glycosylated LDL was expressed as a percentage of the total LDL. Intra-assay precision for percentage LDL glycosylation was 7.7% for a non-diabetic subject and 7.3% for a diabetic patient. The inter-assay precision varied between 3.2% and 11.3%.
range in keeping with a fairly constant and uniformly low plasma glucose level. Glycosylated LDL levels correlated with plasma glucose at the time of sampling (Fig. 2 , r = 0.72; p < 0.0001). This finding confirms that those patients with higher ambient plasma glucose levels due to poor glycaemic control have increased non-enzymatic glycosylation of LDL. Similarly, we found that glycosylated LDL correlated with other parameters of glycaemic control such as glycosylated haemoglobin and glycosylated plasma proteins.
Our results are similar to those reported by Lyons et al. [1] . However, these workers used a more complex method of measuring LDL glycosylation involving reduction of glycosylamine adducts with tritiated sodium borohydride, acid hydrolysis and chromatography. The affinity chromatography method we describe is less time-consuming and provides a simple, precise way of measuring glycosylation of LDL. Non-enzymatic glycosylation of LDL is greater in diabetic patients than non-diabetic control subjects. LDL glycosylation correlates with glycaemic control. Since glycosylated LDL has been shown to be selectively taken up by the monocyte-macrophage scavenger cells [5, 6 ] the increased quantities of glyeosylated LDL found in diabetic patients might contribute to the severe and premature atherosclerosis which occurs in diabetes mellitus. 
Elevated serum uric acid
Dear Sir, We were very interested in the report of Modan and colleagues, which demonstrated a positive association of serum uric acid with plasma insulin response to an OGTF [1] . The authors concluded that elevated serum uric acid is a feature of hyperinsulinaemia/insulin resistance.
What remains unknown, however, is whether it is the hyperinsulinaemia per se or the insulin-resistant state that is responsible for the elevation in serum uric acid. In this regard, we recently studied 5 normal women by the hyperinsulinaemic-euglycaemic clamp technique for 12 h [2] . During the clamp mean (4-SE) serum insulin was 11.25 _+_ 1.80 nmol/1, while serum glucose was maintained at 6.414-0.28 mmol/1. During the insulin infusion serum uric acid levels progressively fell from a median (and range) value of 286 (149-381) umol/l at 0 h to 226 (125-327) lxmol/1 at 12 h (p < 0.05 by two-tailed Wilcoxon signed rank test).
Our data suggest that hyperinsulinaemia decreases serum uric acid, and that it is the insulin-resistant state which is responsible for the elevated serum uric acid levels in the study by Modan and colleagues. This explanation would also be consistent with that study's observation that newly-diagnosed diabetic patients tended to have elevated serum uric acid levels despite a reduction in sum insulin levels [1] .
Yours sincerely, J. E. Nestler, J. N. Clore and W. G. Blackard
Familial diabetes mellitus
Dear Sir,
In a recent issue of Diabetologia, Bodansky and Kelly [1] describe a diabetes syndrome characterised by apparent autosomal dominant inheritance, variable clinical severity, and insulinopoenia. In two newly diagnosed patients, islet cell autoantibodies were absent. As well, evidence of an autoimmune aetiopathogenesis was not supported by HLA typing as only two of the seven patients that were HLA typed carried a high risk allele for Type I (insulin-dependent) diabetes, DR4. No patient carried DR3.
We were struck by the similarity of this familial diabetes syndrome to the atypical diabetes syndrome that we have recently described in Black Americans [2] . Our patients were initially diagnosed as having Type 1 diabetes, while months to years later their dependency on insulin waned or disappeared. Our patients similarly lacked islet cell autoantibodies and high-risk Type 1 diabetes alleles, and insulin secretion as measured by C-peptide response to a mixed meal (Sustacal) was intermediate between control subjects and patients with Type 1 diabetes. Atypical diabetes in Black Americans was
